1995
DOI: 10.1111/j.1476-5381.1995.tb15103.x
|View full text |Cite
|
Sign up to set email alerts
|

Correlation of cyclic AMP accumulation and relaxant actions of salmeterol and salbutamol in bovine tracheal smooth muscle

Abstract: 1 The ability of salmeterol to stimulate cyclic AMP accumulation and relaxation has been compared with that of salbutamol in bovine tracheal smooth muscle. In addition, the anti-spasmogenic effects of these agents and their abilities to modulate histamine-stimulated [3H]-inositol phosphate accumulation have also been investigated.2 In tissue strips, a close temporal correlation was found to exist between salmeterol (0.1 puM)-induced relaxation of methacholine (500 nM)-induced tone and cyclic AMP accumulation, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
10
0

Year Published

1997
1997
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(13 citation statements)
references
References 30 publications
3
10
0
Order By: Relevance
“…Salbutamol, normally considered a β 2 adrenergic agonist, has been shown to inhibit stimulation by histamine if used as a pretreatment. 17 This is consistent with salbutamol stimulation of histamine H 1 receptor followed by desensitization, which makes it subsequently unresponsive to histamine. Although 9 well-characterized receptor:agonist pairs, including melanocortin MC 1 :NDP-MSH, melanocortin MC 3 :NDP-MSH, APJ:apelin-13, bradykinin B 1 :des-arg 10 -kallidin, CCR1: RANTES, CCR5:RANTES, CXCR5:BCA-1, GPR43:propionate, and GPR68:SPC, did not elicit a calcium flux response, we did not observe any false positives.…”
Section: Gpcr Agonist Selectivity Screensupporting
confidence: 77%
“…Salbutamol, normally considered a β 2 adrenergic agonist, has been shown to inhibit stimulation by histamine if used as a pretreatment. 17 This is consistent with salbutamol stimulation of histamine H 1 receptor followed by desensitization, which makes it subsequently unresponsive to histamine. Although 9 well-characterized receptor:agonist pairs, including melanocortin MC 1 :NDP-MSH, melanocortin MC 3 :NDP-MSH, APJ:apelin-13, bradykinin B 1 :des-arg 10 -kallidin, CCR1: RANTES, CCR5:RANTES, CXCR5:BCA-1, GPR43:propionate, and GPR68:SPC, did not elicit a calcium flux response, we did not observe any false positives.…”
Section: Gpcr Agonist Selectivity Screensupporting
confidence: 77%
“…It is also interesting to note that salmeterol demonstrated an equivalent rapid increase in cyclic AMP accumulation in cultured HASM cells compared to the other agonists used in this study, which is distinct from its slow onset of action in airway smooth muscle (Naline et al ., 1994; Anderson et al ., 1996). This finding is in agreement with similar studies performed in rat B50 neuroblastoma cells (McCrea & Hill, 1993), bovine tracheal smooth muscle (Ellis et al ., 1995), CHO‐K1 cells transfected with the human β 2 adrenoceptor (McDonnell et al ., 1998), and for activation of adenylyl cyclase activity in mouse L‐cells transfected with the hamster β 2 adrenoceptor (Clark et al ., 1996) and the human epithelial cell line BEAS‐2B (January et al ., 1998). This is presumably related to cell monolayers being used instead of tissue which significantly reduces the diffusion barrier to the drug.…”
Section: Discussionmentioning
confidence: 99%
“…There is no evidence from studies of bronchodilatation that chronic salmeterol treatment induces tolerance (desensitization) to its bronchodilating effects, although there is evidence that tolerance develops to its protective effects against a bronchoconstrictor stimulus (Cheung et al , 1992; Ramage et al , 1994; Bhagat et al , 1995). One of the primary actions of β 2 ‐adrenoceptor agonists in the relaxation of smooth muscle is the activation of adenylyl cyclase (Johnson et al , 1993), and the relaxant effects of salmeterol on airway smooth muscle are directly correlated with the activation of adenylyl cyclase and subsequent intracellular accumulation of adenosine 3′:5′‐cyclic monophosphate (cyclic AMP) (Ellis et al , 1995). However, there have been few insights into the cellular mechanisms of salmeterol activation and desensitization of β 2 ‐adrenoceptor stimulation of adenylyl cyclase.…”
Section: Introductionmentioning
confidence: 99%